Citation

Legrand E, Hoppé E, Bouvard B, Audran M. Rev. Prat. 2012; 62(2): 193-197.

Vernacular Title

Osteoporose chez l'homme.

Affiliation

Service de rhumatologie et pôle ostéo-articulaire, CHU d'Angers, université d'Angers, UNAM, 49933 Angers. erlegrand@chu-angers.fr

Copyright

(Copyright © 2012, J B Bailliere et Fils)

DOI

unavailable

PMID

22408860

Abstract

Epidemiologic studies have shown that 25% of osteoporotic fractures occur in men. Their prognosis is poor with one third of deaths in the year following the proximal femur fracture. Screening is based on the analysis of risk factors (prolonged corticosteroid therapy, anti androgen, smoking or alcohol abuse, liver disease or chronic inflammatory diseases), taking into account fracture history and bone density measurement. The prescription of bisphosphonates or teriparatide must be preceded by an etiologic investigation, a withdrawal of bone loss-induced drugs (tobacco, alcohol, steroids), a recovery of walking and a specific action on fall risk, especially after 70 years.

Language: fr